Nkx2-1: a novel tumor biomarker of lung cancer

被引:31
作者
Yang, Li [1 ,2 ]
Lin, Min [3 ]
Ruan, Wen-jing [1 ]
Dong, Liang-liang [1 ]
Chen, En-guo [1 ]
Wu, Xiao-hong [1 ]
Ying, Ke-jing [1 ]
机构
[1] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Key Lab Biotherapy Zhejiang Prov,Dept Resp Med, Hangzhou 310016, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Resp Med, Hangzhou 310006, Zhejiang, Peoples R China
[3] Zhejiang Chinese Med Univ, Affiliated Hosp 3, Dept Radiol, Hangzhou 310005, Zhejiang, Peoples R China
来源
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B | 2012年 / 13卷 / 11期
关键词
Nkx2-1; TTF-1; Lung cancer; Biomarker; Diagnosis; Prognosis; Therapy; TRANSCRIPTION FACTOR-I; PROTEIN-B GENE; MERKEL CELL-CARCINOMA; TTF-1; MESSENGER-RNA; SP-A GENE; THYROID TRANSCRIPTION; PRIMARY SITE; BRONCHIOLOALVEOLAR CARCINOMA; METASTATIC ADENOCARCINOMAS; CLINICAL-SIGNIFICANCE;
D O I
10.1631/jzus.B1100382
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nkx2-1 (Nkx homeobox-1 gene), also known as TTF-1 (thyroid transcription factor-1), is a tissue-specific transcription factor of the thyroid, lung, and ventral forebrain. While it has been shown to play a critical role in lung development and lung cancer differentiation and morphogenesis, molecular mechanisms mediating Nkx2-1 cell- and tissue-specific expression in normal and cancerous lungs have yet to be fully elucidated. The recent identification of prognostic biomarkers in lung cancer, particularly in lung adenocarcinoma (ADC), and the different reactivity of patients to chemotherapeutic drugs have opened new avenues for evaluating patient survival and the development of novel effective therapeutic strategies. The function of Nkx2-1 as a proto-oncogene was recently characterized and the gene is implicated as a contributory factor in lung cancer development. In this review, we summarize the role of this transcription factor in the development, diagnosis, and prognosis of lung cancer in the hope of providing insights into the utility of Nkx2-1 as a novel biomarker of lung cancer.
引用
收藏
页码:855 / 866
页数:12
相关论文
共 50 条
  • [31] TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas
    Liu, Z.
    Yanagisawa, K.
    Griesing, S.
    Iwai, M.
    Kano, K.
    Hotta, N.
    Kajino, T.
    Suzuki, M.
    Takahashi, T.
    ONCOGENE, 2017, 36 (26) : 3740 - 3748
  • [32] Detection of netrin-1 as a novel biomarker for diagnosis and chemotherapeutic monitoring of lung cancer
    Zhao, Yuanyuan
    Song, Jing
    Ding, Xuejiao
    Hao, Yu
    Cao, Lihua
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (06)
  • [33] Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?
    Ai, Lizhe
    Yu, Yaqin
    Liu, Xiaoli
    Wang, Chong
    Shi, Jieping
    Sun, Hui
    Yu, Qiong
    FRONTIERS OF MEDICINE, 2014, 8 (01) : 113 - 117
  • [34] LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas
    Tsai, L-H
    Chen, P-M
    Cheng, Y-W
    Chen, C-Y
    Sheu, G-T
    Wu, T-C
    Lee, H.
    ONCOGENE, 2014, 33 (29) : 3851 - 3860
  • [35] Chorea due to TITF1/NKX2-1 mutation: phenotypical description and therapeutic response in a family
    Salvado, Maria
    Boronat-Guerrero, Susanna
    Hernandez-Vara, Jorge
    Alvarez-Sabin, Jose
    REVISTA DE NEUROLOGIA, 2013, 56 (10) : 515 - 520
  • [36] TAZ/WWTR1 Mediates the Pulmonary Effects of NKX2-1 Mutations in Brain-Lung-Thyroid Syndrome
    Moya, Christian M.
    Zaballos, Miguel A.
    Garzon, Lucia
    Luna, Carmen
    Simon, Rogelio
    Yaffe, Michael B.
    Gallego, Elena
    Santisteban, Pilar
    Moreno, Jose C.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (03) : 839 - 852
  • [37] LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas
    L-H Tsai
    P-M Chen
    Y-W Cheng
    C-Y Chen
    G-T Sheu
    T-C Wu
    H Lee
    Oncogene, 2014, 33 : 3851 - 3860
  • [38] Comprehensive genotyping and clinical characterisation reveal 27 novel NKX2-1 mutations and expand the phenotypic spectrum
    Thorwarth, Anne
    Schnittert-Huebener, Sarah
    Schrumpf, Pamela
    Mueller, Ines
    Jyrch, Sabine
    Dame, Christof
    Biebermann, Heike
    Kleinau, Gunnar
    Katchanov, Juri
    Schuelke, Markus
    Ebert, Grit
    Steininger, Anne
    Boennemann, Carsten
    Brockmann, Knut
    Christen, Hans-Juergen
    Crock, Patricia
    deZegher, Francis
    Griese, Matthias
    Hewitt, Jacqueline
    Ivarsson, Sten
    Huebner, Christoph
    Kapelari, Klaus
    Plecko, Barbara
    Rating, Dietz
    Stoeva, Iva
    Ropers, Hans-Hilger
    Grueters, Annette
    Ullmann, Reinhard
    Krude, Heiko
    JOURNAL OF MEDICAL GENETICS, 2014, 51 (06) : 375 - 387
  • [39] Negative NKX2-1 (TTF-1) as Temporary Surrogate Marker for Treatment Selection During EGFR-Mutation Analysis in Patients with Non-Small-Cell Lung Cancer
    Vincenten, Julien
    Smit, Egbert F.
    Vos, Wim
    Gruenberg, Katrien
    Postmus, Pieter E.
    Heideman, Danielle A. M.
    Snijders, Peter J. F.
    Meijer, Gerrit
    Kuik, Joop
    Witte, Birgit I.
    Thunnissen, Erik
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (10) : 1522 - 1527
  • [40] NKX2-1在肺癌中的研究进展
    朱宗鑫
    乔婷婷
    钟亮亮
    姚家祥
    吴志浩
    承德医学院学报, 2020, 37 (05) : 423 - 427